Skip to content

GRoup A StrePtococcus

Gene Expression in Isolates of Group A Streptococci Recovered From Patients Who Are Carriers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01558804
Acronym
GRASP
Enrollment
180
Registered
2012-03-20
Start date
2011-05-09
Completion date
2028-06-01
Last updated
2026-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Streptococcal Pharyngitis

Keywords

Streptococcus pyogenes, Streptococcus

Brief summary

The purpose of the research is to help understand why some children become carriers of strep and whether children who are carriers need to be treated with antibiotics.

Detailed description

The overall objective of this investigation is to understand the differences in Group A streptococci in children who are acutely infected from those who are carriers. The hypothesis is that when in the carrier state, GAS exhibits unique transcriptional profiles that differ from those of the acute infection state. The investigators expect transcriptional profiles of GAS to provide important information regarding the changes the organism undergoes when transitioning between acute infection and carriage. The specific aims of this study are: 1. To collect longitudinal participant-samples from acute and carriage phases of GAS infection and compare transcriptomic profiles and whole genome sequences of GAS recovered from acute and carrier pharyngeal swabs obtained from the same participants. 2. To evaluate how identified differentially expressed genes, or observed genetic polymorphisms, influence GAS models of bacterial colonization and pathogenesis. To do this, the investigators will to identify 12 children with acute pharyngitis due to Group A streptococcus (GAS) who are pharyngeal carriers of GAS. Thirty percent of children 4 to 16 years of age with acute pharyngitis occurring between October and May will have a positive culture or rapid antigen detection test for GAS. Approximately 8-10% of these children with pharyngitis and a positive culture or rapid antigen detection test (RADT) for GAS will be carriers. Therefore,180 participants will need to be enrolled.

Interventions

OTHERIdentifying group A strep carriers

At study entry, at 14 days, and if follow up is positive, again in 14-21 days: Standard culture for GAS and analysis of mRNA.

Sponsors

University of Wisconsin, Madison
Lead SponsorOTHER
National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
5 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Children ages 5-15 years * Positive rapid antigen detection test for group A streptococcus * Parent or legal guardian present and able to provide consent * Provider prescribes treatment with a beta lactam antibiotic * English speaking

Exclusion criteria

* Unable to take beta lactam antibiotics * Other concurrent bacterial infection, i.e., pneumonia

Design outcomes

Primary

MeasureTime frameDescription
Identifying children who are pharyngeal carriers of Group A streptococcus2 weeksThe specific aim of this study is to identify 30 children with acute pharyngitis due to Group A streptococcus (GAS) and 30 children who are pharyngeal carriers of GAS. Thirty percent of children 4 to 16 years of age with acute pharyngitis occurring between October and May will have a positive culture or rapid antigen detection test for GAS. Approximately 10-15% of these children with pharyngitis and a positive culture or rapid antigen detection test (RADT) for GAS will be carriers

Countries

United States

Contacts

CONTACTCherie Schommer, BA
schommer2@wisc.edu608-262-2631
PRINCIPAL_INVESTIGATORGregory DeMuri, MD

University of Wisconsin, Madison

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 19, 2026